ENGLISH

Investigators

Basic Information
Investigator
Ae-Young Her (Heo)
Country
South Korea
Affiliation
Kangwon National University
Specialty
Cardiology
Clinical Trial History
Clinical Trial Experience
10 year
Multicenter Clinical Trial Performance Status
Yes
IND Submission History (Count)
0 Count
Related Papers/Publications (Count)
71 Count
Clinical Trial Details
Total 16
Trial Title

Ticagrelor Monotherapy After 3 Months in the Patients Treated with New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Therapy Area
Cardiovascular
Indication(s)
Unstable Angina
Investigator’s Role
Co-Author
Trial Phase
Phase IV
Trial Status
Completed
Trial Title

Ticagrelor Monotherapy After 3 Months in the Patients Treated with New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Therapy Area
Cardiovascular
Indication(s)
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Investigator’s Role
Co-Author
Trial Phase
Phase IV
Trial Status
Completed
Trial Title

Ticagrelor Monotherapy After 3 Months in the Patients Treated with New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Therapy Area
Cardiovascular
Indication(s)
Thrombosis
Investigator’s Role
Co-Author
Trial Phase
Phase IV
Trial Status
Completed
Trial Title

Ticagrelor Monotherapy After 3 Months in the Patients Treated with New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Therapy Area
Cardiovascular
Indication(s)
Stroke
Investigator’s Role
Co-Author
Trial Phase
Phase IV
Trial Status
Completed
Trial Title

Ticagrelor Monotherapy After 3 Months in the Patients Treated with New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Therapy Area
Cardiovascular
Indication(s)
Myocardial Infarction
Investigator’s Role
Co-Author
Trial Phase
Phase IV
Trial Status
Completed
Trial Title

Ticagrelor Monotherapy After 3 Months in the Patients Treated with New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

Therapy Area
Cardiovascular
Indication(s)
Acute Coronary Syndrome
Investigator’s Role
Co-Author
Trial Phase
Phase IV
Trial Status
Completed
Trial Title

Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients with Large Coronary Artery Disease(REVERSE)

Therapy Area
Cardiovascular
Indication(s)
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Investigator’s Role
Contact Person; Principal Investigator
Trial Phase
Phase III
Trial Status
Ongoing, recruiting
Trial Title

Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients with Large Coronary Artery Disease(REVERSE)

Therapy Area
Cardiovascular
Indication(s)
Coronary Stenosis
Investigator’s Role
Contact Person; Principal Investigator
Trial Phase
Phase III
Trial Status
Ongoing, recruiting
Trial Title

Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients with Large Coronary Artery Disease(REVERSE)

Therapy Area
Cardiovascular
Indication(s)
Acute Coronary Syndrome
Investigator’s Role
Contact Person; Principal Investigator
Trial Phase
Phase III
Trial Status
Ongoing, recruiting
Trial Title

Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients with Large Coronary Artery Disease(REVERSE)

Therapy Area
Cardiovascular
Indication(s)
Myocardial Ischemia
Investigator’s Role
Contact Person; Principal Investigator
Trial Phase
Phase III
Trial Status
Ongoing, recruiting
Trial Title

Evaluation of Effectiveness and Safety of Biomime Stent in the Korean Patients with Acute Coronary Syndrome; Multicenter, Prospective, Observational Clinical Trial

Therapy Area
Cardiovascular
Indication(s)
Angina (Angina Pectoris)
Investigator’s Role
Co-Author
Trial Phase
Phase IV
Trial Status
Completed
Trial Title

Evaluation of Effectiveness and Safety of Biomime Stent in the Korean Patients with Acute Coronary Syndrome; Multicenter, Prospective, Observational Clinical Trial

Therapy Area
Cardiovascular
Indication(s)
Myocardial Infarction
Investigator’s Role
Co-Author
Trial Phase
Phase IV
Trial Status
Completed
Trial Title

Evaluation of Effectiveness and Safety of Biomime Stent in the Korean Patients with Acute Coronary Syndrome; Multicenter, Prospective, Observational Clinical Trial

Therapy Area
Cardiovascular
Indication(s)
Acute Coronary Syndrome
Investigator’s Role
Co-Author
Trial Phase
Phase IV
Trial Status
Completed
Trial Title

A Prospective, Multicenter, Randomized Clinical Study Comparing the Effectiveness and Safety of Post-stabilization Prasugrel-only Antiplatelet Therapy and Dual Antiplatelet Therapy with Clopidogrel in Patients with Acute Coronary Syndrome Who Underwent Complex-high-risk Coronary Intervention

Therapy Area
Cardiovascular
Indication(s)
Unstable Angina
Investigator’s Role
Principal Investigator
Trial Phase
Phase III
Trial Status
Ongoing, recruiting
Trial Title

A Prospective, Multicenter, Randomized Clinical Study Comparing the Effectiveness and Safety of Post-stabilization Prasugrel-only Antiplatelet Therapy and Dual Antiplatelet Therapy with Clopidogrel in Patients with Acute Coronary Syndrome Who Underwent Complex-high-risk Coronary Intervention

Therapy Area
Cardiovascular
Indication(s)
Acute Coronary Syndrome
Investigator’s Role
Principal Investigator
Trial Phase
Phase III
Trial Status
Ongoing, recruiting
Trial Title

A Prospective, Multicenter, Randomized Clinical Study Comparing the Effectiveness and Safety of Post-stabilization Prasugrel-only Antiplatelet Therapy and Dual Antiplatelet Therapy with Clopidogrel in Patients with Acute Coronary Syndrome Who Underwent Complex-high-risk Coronary Intervention

Therapy Area
Cardiovascular
Indication(s)
Percutaneous Coronary Intervention
Investigator’s Role
Principal Investigator
Trial Phase
Phase III
Trial Status
Ongoing, recruiting
ViewList